Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis.
Giacomo EmmiGiovanni M RossiMaria L UrbanElena SilvestriDomenico PriscoMatteo GoldoniAugusto VaglioPublished in: Annals of the rheumatic diseases (2017)